ReShape Lifesciences Inc (RSLS) — Financial Flexibility Index
ReShape Lifesciences Inc (RSLS) has a Financial Flexibility Index of -1.40x as of June 2025. Free cash flow of $-4.49 Million (operating CF $-4.49 Million minus capex $0.00) represents -1% of total liabilities ($3.20 Million). Check ReShape Lifesciences Inc (RSLS) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ReShape Lifesciences Inc Financial Flexibility Index (2005–2024)
Historical Financial Flexibility Index trend for ReShape Lifesciences Inc across 20 annual periods. For the full cash flow conversion analysis, see ReShape Lifesciences Inc cash flow conversion.
Annual Financial Flexibility Index for ReShape Lifesciences Inc (2005–2024)
Year-by-year free cash flow to debt coverage for ReShape Lifesciences Inc. Explore RSLS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.88x | $-4.43 Million | $-4.43 Million | $5.05 Million | ▲ +79.3% |
| 2023 | -4.23x | $-16.92 Million | $-16.96 Million | $4.00 Million | ▼ -45.3% |
| 2022 | -2.91x | $-21.77 Million | $-21.90 Million | $7.48 Million | ▼ -58.6% |
| 2021 | -1.84x | $-15.02 Million | $-15.38 Million | $8.19 Million | ▼ -407.7% |
| 2020 | -0.36x | $-8.16 Million | $-8.55 Million | $22.57 Million | ▲ +60.4% |
| 2019 | -0.91x | $-14.19 Million | $-14.20 Million | $15.55 Million | ▲ +51.4% |
| 2018 | -1.88x | $-27.44 Million | $-27.49 Million | $14.61 Million | ▲ +5.2% |
| 2017 | -1.98x | $-24.45 Million | $-24.59 Million | $12.34 Million | ▲ +60.6% |
| 2016 | -5.03x | $-20.64 Million | $-20.66 Million | $4.10 Million | ▼ -76.5% |
| 2015 | -2.85x | $-22.57 Million | $-22.61 Million | $7.91 Million | ▼ -14.1% |
| 2014 | -2.50x | $-19.29 Million | $-19.38 Million | $7.72 Million | ▼ -62.5% |
| 2013 | -1.54x | $-18.01 Million | $-18.43 Million | $11.71 Million | ▲ +2.4% |
| 2012 | -1.58x | $-22.40 Million | $-22.48 Million | $14.22 Million | ▲ +0.4% |
| 2011 | -1.58x | $-19.68 Million | $-19.94 Million | $12.44 Million | ▼ -4.0% |
| 2010 | -1.52x | $-13.66 Million | $-13.66 Million | $8.98 Million | ▲ +33.9% |
| 2009 | -2.30x | $-24.47 Million | $-24.66 Million | $10.63 Million | ▼ -16.2% |
| 2008 | -1.98x | $-33.42 Million | $-33.67 Million | $16.87 Million | ▼ -20.9% |
| 2007 | -1.64x | $-22.57 Million | $-23.37 Million | $13.77 Million | ▲ +21.3% |
| 2006 | -2.08x | $-15.59 Million | $-16.23 Million | $7.49 Million | ▼ -103.1% |
| 2005 | -1.03x | $-9.83 Million | $-10.28 Million | $9.59 Million | — |